<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03552497</url>
  </required_header>
  <id_info>
    <org_study_id>BIIIP_18</org_study_id>
    <nct_id>NCT03552497</nct_id>
  </id_info>
  <brief_title>The Potential of Radiomics to Differentiate Between Malignant and Benign Bosniak 3 Renal Cysts.</brief_title>
  <acronym>BIII</acronym>
  <official_title>The Potential of Radiomics to Differentiate Between Malignant and Benign Bosniak 3 Renal Cysts.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Aachen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      More than 200,000 new cases of renal cancer are diagnosed in the world each year, with more&#xD;
      than 63,000 new cases in Europe alone. Of those, renal cell carcinoma (RCC) is the most&#xD;
      common type in adults, making up more than 90% of the cases. Deciding on the benign or&#xD;
      malignant nature of some RCC on the basis of medical images (CT, MRI, US) is an issue, which&#xD;
      often leads to unnecessary surgery, morbidity and costs.&#xD;
&#xD;
      A categorization for renal cysts was introduced in the late 1980s known as the Bosniak&#xD;
      classification. The Bosniak classification system classifies them into groups that are benign&#xD;
      (I and II) and those that need surgical resection (III and IV), based on specific imaging&#xD;
      features. However, defining the malignancy of category III lesions still remains a challenge.&#xD;
      Though Bosniak classification for renal cysts is used worldwide and underwent a number of&#xD;
      modifications, Bosniak III cysts still have almost a 1:1 chance of being malignant. So the&#xD;
      problem is that approximately half of the Bosniak category III cystic lesions prove to be&#xD;
      benign after surgery.&#xD;
&#xD;
      The proposed project aims to develop a quantitative image analysis (QIA) based multifactorial&#xD;
      decision support system (mDSS) capable of classifying renal cysts with high accuracy into&#xD;
      benign or malignant status, thus reducing the amount of unnecessary surgeries performed.&#xD;
      Using standard-of-care CT images and clinical parameters, the customized DSS will then guide&#xD;
      experts in planning a safe and effective diagnostic and treatment strategy for all RCC&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 7, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>malignancy classifier</measure>
    <time_frame>1 year</time_frame>
    <description>Machine learning algorithm that can differentiate between malignant and beingn bosniak 3 renal cysts.</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Renal Cyst Complex</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Radiomics</intervention_name>
    <description>The high-throughput extraction of large amounts of quantitative image features from radiographic medical images</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with renal cysts classified as bosniak 3 in one of the collaborating institutes.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent contrast-enhanced CT-Scan, with radiological findings&#xD;
             suggestive of Bosniak 3 renal cyst and have available results for pathology analysis&#xD;
             of the cyst.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CT-Scans that are reformatted or secondary.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6200 MD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 29, 2018</study_first_submitted>
  <study_first_submitted_qc>May 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2018</study_first_posted>
  <last_update_submitted>April 3, 2020</last_update_submitted>
  <last_update_submitted_qc>April 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radiomics</keyword>
  <keyword>Bosniak classification</keyword>
  <keyword>Renal cell carcinoma</keyword>
  <keyword>Medical imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cysts</mesh_term>
    <mesh_term>Kidney Diseases, Cystic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

